Haemoglobin, body mass index and age as risk-factors for paclitaxel- and oxaliplatin-induced peripheral neuropathy

被引：0
|
作者：
Mizrahi, D. [1 ]
Park, S. B. [2 ]
Li, T. [2 ]
Timmins, H. [2 ]
Trinh, T. [1 ]
Au, K. [1 ]
Battaglini, E. [1 ]
Wyld, D. [3 ]
Henderson, R. [4 ]
Grimison, P. [5 ]
Ke, H. [5 ]
Marker, J. [6 ]
Wall, B. [6 ]
Goldstein, D. [1 ]
机构：
[1] UNSW, Prince Wales Clin Sch, Sydney, NSW, Australia
[2] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia
[3] Royal Brisbane & Womens Hosp, Med Oncol, Brisbane, Qld, Australia
[4] Royal Brisbane & Womens Hosp, Neurol, Brisbane, Qld, Australia
[5] Chris OBrien Lifehouse, Med Oncol, Sydney, NSW, Australia
[6] Australasian Gastrointestinal Trials Grp, Consumer Advisory Panel, Sydney, NSW, Australia
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
基金：
英国医学研究理事会;
关键词：
D O I：
10.1016/j.annonc.2020.10.328
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
334MO
引用
收藏
页码：S1371 / S1371
页数：1
相关论文
共 50 条
  • [1] Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy
    Mizrahi, David
    Park, Susanna B.
    Li, Tiffany
    Timmins, Hannah C.
    Trinh, Terry
    Au, Kimberley
    Battaglini, Eva
    Wyld, David
    Henderson, Robert D.
    Grimison, Peter
    Ke, Helen
    Geelan-Small, Peter
    Marker, Julie
    Wall, Brian
    Goldstein, David
    JAMA NETWORK OPEN, 2021, 4 (02) : E2036695
  • [2] Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy
    Taguchi, Kyoji
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2016, 136 (02): : 287 - 296
  • [3] CXCR1/2 inhibition prevents paclitaxel- and oxaliplatin-induced peripheral neuropathy
    Ruffini, P. A.
    Brandolini, L.
    Russo, R.
    Cimini, A.
    Allegretti, M.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S115 - S115
  • [4] Oxaliplatin-induced peripheral neuropathy risk factors and management in Tunisian population
    Zribi, Aref
    Ben Nasr, Sonia
    Hamdi, Syrine
    Ayari, Jihen
    Fendri, Sana
    Balti, Mehdi
    Haddaoui, Abderrazek
    PAN AFRICAN MEDICAL JOURNAL, 2020, 35
  • [5] Comparative Transcriptome of Dorsal Root Ganglia Reveals Distinct Etiologies of Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy in Rats
    Sun, Wuping
    Hao, Yue
    Li, Rongzhen
    Ho, Idy Hiu Ting
    Wu, Songbin
    Li, Nan
    Ba, Xiyuan
    Wang, Jie
    Xiong, Donglin
    Jiang, Changyu
    Xiao, Lizu
    Liu, Xiaodong
    NEUROSCIENCE, 2023, 516 : 1 - 14
  • [6] CHARACTERIZATION OF OXALIPLATIN-INDUCED CHRONIC PAINFUL PERIPHERAL NEUROPATHY IN THE RAT AND COMPARISON WITH THE NEUROPATHY INDUCED BY PACLITAXEL
    Xiao, W. H.
    Zheng, H.
    Bennett, G. J.
    NEUROSCIENCE, 2012, 203 : 194 - 206
  • [7] The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancer
    Yamaguchi, Kyoko
    Kusaba, Hitoshi
    Makiyama, Akitaka
    Mitsugi, Kenji
    Uchino, Keita
    Tamura, Shingo
    Shibata, Yoshihiro
    Esaki, Taito
    Ito, Mamoru
    Takayoshi, Kotoe
    Tsuchihashi, Kenji
    Arita, Shuji
    Ariyama, Hiroshi
    Akashi, Koichi
    Baba, Eishi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (04) : 625 - 633
  • [8] The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancer
    Kyoko Yamaguchi
    Hitoshi Kusaba
    Akitaka Makiyama
    Kenji Mitsugi
    Keita Uchino
    Shingo Tamura
    Yoshihiro Shibata
    Taito Esaki
    Mamoru Ito
    Kotoe Takayoshi
    Kenji Tsuchihashi
    Shuji Arita
    Hiroshi Ariyama
    Koichi Akashi
    Eishi Baba
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 625 - 633
  • [9] Risk factors for oxaliplatin-induced peripheral neuropathy: a systematic review and meta-analysis
    Wang, R. -Y.
    Lin, X. -L.
    Xiang, S. -T.
    Sun, Q. -H.
    Ding, X. -H.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (11) : 4028 - 4043
  • [10] Association of age and body mass index with paclitaxel-induced peripheral neuropathy in patients with breast cancer
    Ghoreishi, Z.
    Esfahani, A.
    Keshavarz, S.
    ANNALS OF ONCOLOGY, 2016, 27
12345